Neuroprotection with Bcl-220–34 peptide against trauma
暂无分享,去创建一个
[1] S. Cory,et al. The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4 , 1998, The EMBO journal.
[2] I. Macrae,et al. Influence of Ischemia and Reperfusion on the Course of Brain Tissue Swelling and Blood–Brain Barrier Permeability in a Rodent Model of Transient Focal Cerebral Ischemia , 1997, Experimental Neurology.
[3] R. Oppenheim,et al. Programmed Cell Death in the Developing Nervous System , 1996, Brain pathology.
[4] J. Hunter,et al. Functional dissection of the human Bc12 protein: sequence requirements for inhibition of apoptosis , 1996, Molecular and cellular biology.
[5] R. A. Wallis,et al. Traumatic neuroprotection with inhibitors of nitric oxide and ADP-ribosylation , 1996, Brain Research.
[6] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[7] R. A. Wallis,et al. Protection from hypoxic and N-methyl-D-aspartate injury with azelastine, a leukotriene inhibitor. , 1993, European journal of pharmacology.
[8] L. Jarrard. On the role of the hippocampus in learning and memory in the rat. , 1993, Behavioral and neural biology.
[9] M. Dyer,et al. Ultrastructural localization of bcl-2 protein. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[10] H. Hansson,et al. Reversible blood-brain barrier dysfunction to peroxidase after a small stab wound in the rat cerebral cortex. , 1976, Acta neuropathologica.
[11] S. Korsmeyer,et al. Bcl-2 gene family in the nervous system. , 1997, Annual review of neuroscience.